Cargando…
Retraction: Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
Autores principales: | Jiang, Yueqiang, Ma, Yanling, Li, RuiChao, Sun, JianHai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760265/ https://www.ncbi.nlm.nih.gov/pubmed/36528880 http://dx.doi.org/10.18632/oncotarget.28325 |
Ejemplares similares
-
Correction: Colon cancer-induced interleukin-35 inhibits betacatenin- mediated pro-oncogenic activity
por: Jiang, Yueqiang, et al.
Publicado: (2018) -
Colon cancer-induced interleukin-35 inhibits beta-catenin-mediated pro-oncogenic activity
por: Jiang, QiangYue, et al.
Publicado: (2017) -
Retracted: Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023) -
MicroRNA-665 Inhibits the Oncogenicity of Retinoblastoma by Directly Targeting High-Mobility Group Box 1 and Inactivating the Wnt/β-Catenin Pathway [Retraction]
Publicado: (2021) -
Retraction: Molecular characterization of Legionella pneumophila-induced interleukin-8 expression in T cells
por: Takamatsu, Reika, et al.
Publicado: (2011)